IBDEI1KT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25191,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,25191,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,25191,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,25192,0)
 ;;=K76.0^^107^1214^12
 ;;^UTILITY(U,$J,358.3,25192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25192,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,25192,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,25192,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,25193,0)
 ;;=K76.89^^107^1214^18
 ;;^UTILITY(U,$J,358.3,25193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25193,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,25193,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,25193,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,25194,0)
 ;;=K71.6^^107^1214^32
 ;;^UTILITY(U,$J,358.3,25194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25194,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,25194,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,25194,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,25195,0)
 ;;=K75.9^^107^1214^17
 ;;^UTILITY(U,$J,358.3,25195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25195,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25195,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,25195,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,25196,0)
 ;;=K71.0^^107^1214^24
 ;;^UTILITY(U,$J,358.3,25196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25196,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,25196,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,25196,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,25197,0)
 ;;=K71.10^^107^1214^30
 ;;^UTILITY(U,$J,358.3,25197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25197,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,25197,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,25197,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,25198,0)
 ;;=K71.11^^107^1214^31
 ;;^UTILITY(U,$J,358.3,25198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25198,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,25198,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,25198,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,25199,0)
 ;;=K71.2^^107^1214^23
 ;;^UTILITY(U,$J,358.3,25199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25199,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,25199,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,25199,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,25200,0)
 ;;=K71.3^^107^1214^28
 ;;^UTILITY(U,$J,358.3,25200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25200,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,25200,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,25200,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,25201,0)
 ;;=K71.4^^107^1214^27
 ;;^UTILITY(U,$J,358.3,25201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25201,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,25201,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,25201,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,25202,0)
 ;;=K75.81^^107^1214^19
 ;;^UTILITY(U,$J,358.3,25202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25202,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,25202,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,25202,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,25203,0)
 ;;=K75.89^^107^1214^16
 ;;^UTILITY(U,$J,358.3,25203,1,0)
 ;;=^358.31IA^4^2
